Friday, 31 March 2017

U.S. judge invalidates Acorda multiple sclerosis drug patents

(Reuters) - A federal judge in Delaware on Friday struck down key patents held by Acorda Therapeutics related to its multiple sclerosis drug Ampyra.


Youth with diabetes need vision loss screening

(Reuters Health) – Diabetes can lead to blindness, but children and teens with diabetes may not receive recommended eye exams in the years following their diagnosis, a U.S. study suggests.


NIAID begins vaccinations in a mid-stage trial for Zika

(Reuters) - The U.S. National Institute of Allergy and Infectious Diseases (NIAID) said on Friday that vaccinations have begun in a mid-stage trial testing an experimental DNA vaccine for Zika.